Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePfizer and Lilly shoulder novel pain-drug risks.AuthorsSinha, GunjanAbstractThe article reports on the deal between pharmaceutical companies New York-based Pfizer and Eli Lilly & Co. in Indianapolis, Indiana in October 2013 for the development of the former's anti-nerve growth factor drug known as tanezumab.SubjectsPFIZER Inc.; ELI Lilly &; Co.; DRUG developmentPublicationNature Biotechnology, 2014, Vol 32, Issue 1, p9ISSN1087-0156Publication typeArticleDOI10.1038/nbt0114-9b